Document is current
Any future updates will be listed below
-
Authors
Johansson, Viktoria https://orcid.org/0000-0003-3775-7245
Jakobsson, Joel
Fortgang, Rebecca G.
Zetterberg, Henrik
Blennow, Kaj
Cannon, Tyrone D.
Hultman, Christina M.
Wetterberg, Lennart
Landén, Mikael
-
Funding
Funding for this research was provided by:
Stockholm County Council and the Karolinska Institutet (ALF 20100305)
Stockholm County Council and the Karolinska Institutet (ALF 20090183)
National Institutes of Health (T.D. Cannon RO1 MH52857)
the Swedish Medical Research Council (K2014-62X-14647-12-51)
the Swedish Medical Research Council (K2010-61P-21568-01-4)
Stiftelsen för Strategisk Forskning (KF10-0039)
- License Information
-
More Information
Article History
Received: 8 June 2016
Accepted: 13 December 2016
First Online: 30 December 2016
Compliance with ethical standards
:
: Tyrone Cannon is a consultant to Boehringer Ingelheim Pharmaceuticals and Kaj Blennow has served as consultant and at advisory boards for Fujirebio Europe, IBL International and Roche Diagnostics. Viktoria Johansson, Joel Jakobsson, Rebecca G Fortgang, Henrik Zetterberg, Christina M Hultman, Lennart Wetterberg, and Mikael Landén have no financial interests to declare.
